| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.08 | 0.005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.005 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |